Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems.
BACKGROUND
The introduction of prestorage white cell (WBC) reduction in random-donor platelet concentrates in Canada has increased the occurrence of particulate material in PCs. The effects of filtration on platelet activation state and the activation of plasma enzyme systems were assessed.


METHODS
Particulate material was examined by light microscopy, electron microscopy, protein electrophoresis, and biochemical analysis. Thirty PCs (10 unfiltered, 20 filtered) were examined during processing and 5-day storage for pH, platelet count and mean volume, morphology, activation marker expression, and hypotonic shock response. Complement activation, thrombin generation, and fibrinolysis were assessed by using specific enzyme immunoassays or chromogenic assays.


RESULTS
By all analyses, the particulate material appeared to be platelet aggregates. Platelets exposed to WBC-reduction filters expressed a significantly higher level of activation markers CD62 and CD63, altered morphology, and increased platelet microparticles throughout the storage period than did unfiltered platelets. Complement activation at the C3 level was significantly increased in filtered units with little evidence of coagulation or fibrinolytic system activation.


CONCLUSIONS
Exposure of platelets to filters during prestorage WBC reduction increased platelet activation and mildly increased complement activation over the levels during the storage period. These alterations can contribute to the formation of irreversible platelet aggregates during processing.
Canadian Blood Services, Vancouver Centre, and the Department of Pathology, University of British Columbia, Canada. ddevine@pathology.ubc.ca
D V
DV
Devine
A J
AJ
Bradley
E
E
Maurer
E
E
Levin
S
S
Chahal
K
K
Serrano
M I
MI
Gyongyossy-Issa
D015703:Antigens, CD / Q000097:blood; D001782:Blood Donors; D001792:Blood Platelets / Q000737:chemistry / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000097:blood; D003167:Complement Activation / Q000502:physiology; D005434:Flow Cytometry; D006801:Humans; D007937:Leukapheresis; D010949:Plasma / Q000201:enzymology*; D015539:Platelet Activation; D010974:Platelet Aggregation; D010980:Platelet Membrane Glycoproteins; D060149:Tetraspanin 30; D013917:Thrombin / Q000032:analysis*; D013997:Time Factors
D015703:Antigens, CD; C554586:CD63 protein, human; D015815:Cell Adhesion Molecules; D010980:Platelet Membrane Glycoproteins; D060149:Tetraspanin 30; D013917:Thrombin